140mg Nitib Ibrutinib Capsule

140mg Nitib Ibrutinib Capsule Specification

Pacakaging (Quantity Per Box)
1 bottle of 30 capsules

Origin of Medicine
India

Life Span
24 months from date of manufacture

Indication
Treatment of various types of B-cell malignancies, including MCL, CLL, SLL, and Waldenstroms macroglobulinemia

Brand Name
Nitib

Dosage Form
Solid

Salt Composition
Ibrutinib

Packaging Type
Bottle

Drug Type
Prescription Only Medicine

Ingredients
Ibrutinib 140mg

Physical Form
Capsule

Function
Anticancer medication, Brutons tyrosine kinase (BTK) inhibitor

Recommended For
Adults with mantle cell lymphoma (MCL), chronic lymphocytic leukemia (CLL), and Waldenstroms macroglobulinemia

Dosage
As prescribed by physician

Dosage Guidelines
Take exactly as directed by the healthcare provider

Suitable For
Adults

Quantity
30 Capsules per bottle

Storage Instructions
Store below 30C in a dry place, away from direct sunlight

ATC Code
L01XE27

Contraindications
Known hypersensitivity to Ibrutinib or any component of the formulation

Shape
Opaque hard gelatin capsule

Administration Route
Oral

Prescription/Non Prescription
Prescription

Precautions
Use with caution in patients with bleeding disorders, atrial fibrillation, or hepatic impairment

Therapeutic Class
Antineoplastic Agent

Color
Light yellow

Maximum Retail Price
As per regulatory norms

Manufactured By
Hetero Healthcare Limited

Side Effects
Diarrhea, fatigue, musculoskeletal pain, rash, nausea, bruising, and fever

140mg Nitib Ibrutinib Capsule Trade Information

Minimum Order Quantity
10 Pieces

Supply Ability
5000 Pieces Per Month

Delivery Time
7 Days

About 140mg Nitib Ibrutinib Capsule

Packaging Size	30 Capsules
Strength	140 mg
Packaging Type	Box
Dose	140mg
Treatment	mantle-cell lymphoma and blood cancer (chronic lymphocytic leukemia)
Manufacturer	Hetero Healthcare Limited

Nitib 140mg Capsule is used in the treatment of mantle-cell lymphoma and blood cancer (chronic lymphocytic leukemia). It is also used in chronic lymphocytic leukaemia who have received at least one prior therapy.

Nitib 140mg Capsule is taken in a dose as advised by the doctor. The duration of treatment varies on the basis of your response to treatment. Your doctor may get regular blood tests to check number of blood cells during treatment with this medicine. It is known to reduce the number of blood cells in your blood thereby, increasing the susceptibility to infections. It may cause headache, diarrhea, and nausea as its side effects.

Powerful BTK Inhibitor for B-cell Malignancies

Nitib (Ibrutinib 140mg) is formulated to target and inhibit Bruton's tyrosine kinase, a critical enzyme in the survival of cancerous B-cells. By blocking this pathway, Nitib effectively limits the growth and proliferation of malignant cells, offering a significant therapeutic benefit for adults diagnosed with certain lymphomas and leukemias.

Precise Administration and Professional Guidance

Nitib capsules are intended for oral administration and should only be consumed under the supervision of a qualified healthcare provider. Dosages are tailored to suit each patient's needs and medical profile, ensuring safety and optimum benefit. It is essential to adhere strictly to the dosage guidelines provided by your physician.

Safety, Storage, and Handling

To maintain the efficacy of Nitib, store the capsules below 30C in a dry place, shielded from direct sunlight. Handle with clean, dry hands and keep out of reach of children. Be mindful of potential side effects and contraindications-always consult your healthcare provider with any concerns.

FAQ's of 140mg Nitib Ibrutinib Capsule:

Q: How should Nitib Ibrutinib capsules be taken for best results?

A: Nitib Ibrutinib capsules should be taken orally, exactly as prescribed by your healthcare provider. Do not alter the dosage or frequency without consulting your doctor. Swallow the capsule whole with water, and take it at the same time each day to help maintain consistent blood levels.

Q: What are the key benefits of using Nitib for cancer treatment?

A: Nitib is specifically indicated for the treatment of various B-cell malignancies, including mantle cell lymphoma, chronic lymphocytic leukemia, and Waldenstrom's macroglobulinemia. By inhibiting BTK, it interferes with cancer cell growth and survival, improving patient outcomes in these serious conditions.

Q: When should Nitib not be used?

A: Nitib is contraindicated in patients with known hypersensitivity to Ibrutinib or any component of the formulation. It should not be used without a physician's prescription and careful evaluation of your medical history.

Q: Where should I store Nitib capsules to ensure their effectiveness?

A: Store Nitib capsules below 30C in a dry environment, away from direct sunlight and moisture. Keep the bottle tightly closed and out of the reach of children.

Q: What precautions should be followed while using Nitib?

A: Patients should use Nitib with caution if they have a history of bleeding disorders, atrial fibrillation, or liver impairment. Regular monitoring by your healthcare provider is recommended to manage any potential side effects or complications.

Q: What side effects may occur with Nitib usage?

A: Common side effects include diarrhea, fatigue, musculoskeletal pain, rash, nausea, bruising, and fever. Inform your healthcare provider about any unusual or severe symptoms you experience while on this medication.